Dr. Michael Haichin has a longstanding fascination about substances that straddle the artificially constructed drug/medicine divide. This interest led him to pursue a B.Sc in Pharmacology from McGill University, followed by a PharmD from the University of Toronto. He aims to provide accurate and insightful information about psychedelics and has contributed as a Writer, Associate Editor, and Lead Editor for Psychedelic Science Review.
The Psilocybin vs. Escitalopram Trial – Part 2
A deep dive into the strengths and limitations of the trial.